HemoShear, a human disease biology company co-founded by Rhodes alumnus Dr. Brian R. Wamhoff, has received the prestigious Tibbetts Award presented by the U.S. Small Business Administration and based on the recommendations of a panel of judges.
The Tibbetts Awards are presented to those small businesses and individuals judged to exemplify the best in the Small Business Innovation Research program. Awarded to only 25 companies in 2014, the Tibbetts Award places HemoShear in an elite group of accomplished companies that are driving innovation and stimulating economic growth.
At the awards ceremony recently held in Washington D.C., HemoShear was recognized for its leadership in changing the way drugs are discovered and developed, departing from traditional scientific methods and animal studies in favor of translational tissue systems that more accurately replicate human response.
Wamhoff received a B.S. in biology with a minor in business administration in 1996 from Rhodes, where he also received the Estelle R. Cone Award for philanthropic work at St. Jude Children’s Research Hospital and the Outstanding Student Award for Research in Biology. In 2011, Rhodes presented him the Distinguished Alumnus Award. Wamhoff has been quoted crediting his business and economics classes at Rhodes for his entrepreneurial success.